Primary and secondary cutaneous diffuse large B-cell lymphomas: A multiparameter analysis of 25 cases including fluorescence in situ hybridization for t(14;18) translocation

American Journal of Surgical Pathology

Volumn 27, Issue 3, 2003, Pages 356-364

  Kim, Bong K ^a   Surti, Urvashi ^a   Pandya, Amit G ^b   Swerdlow, Steven H ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

CD10; Cutaneous diffuse large B cell lymphoma; Cutaneous follicle center cell lymphoma; Follicular center cells; T(14; 18)

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; SKIN LYMPHOMA; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0347297430     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200303000-00009     Document Type: Article

References (46)

1. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
2. Almasri NM, Iturraspe JA, Braylan RC. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles. Arch Pathol Lab Med 1998;122: 539-44.
3. Burg G, Dummer R, Kerl H. Classification of cutaneous lymphomas. Dermatol Clin 1994;12:213-7.
4. Carbone A, Gaidano G, Gloghini A, et al. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related nonHodgkin's lymphomas. Blood 1998;91:747-55.
5. Carbone A, Gloghini A, Gaidano G, et al. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. Blood 1998;92:2220-8.
6. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 2001;97:744-51.
7. Chen CC, Raikow RB, Sonmez-Alpan E, et al. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel. Appl Immunohistochem Mol Morphol 2000;8:1-11.
8. Child FJ, Russell-Jones R, Woolford AJ, et al. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. Br J Dermatol 2001;144:735-44.
9. de Leon ED, Alkan S, Huang JC, et al. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell nonHodgkin's lymphomas of small lymphocytes. Mod Pathol 1998;11:1046-51.
10. de Leval L, Ferry JA, Falini B, et al. Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells? Am J Surg Pathol 2001;25: 1277-82.
11. de Leval L, Harris NL, Longtine J, et al. Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol 2001;25:732-41.
12. Fernandez-Vazquez A, Rodriguez-Peralto JL, Martinez MA, et al. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival. Am J Surg Pathol 2001;25:307-15.
13. Franco R, Fernandez-Vazquez A, Rodriguez-Peralto JL, et al. Cutaneous follicular B-cell lymphoma: description of a series of 18 cases. Am J Surg Pathol 2001;25:875-83.
14. Gascoyne RD, Adomat SA, Krajewski S, et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive nonHodgkin's lymphoma. Blood 1997;90: 244-51.
15. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al., eds. Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer, 2001:171-4.
16. Geelen FA, Vermeer MH, Meijer CJ, et al. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol 1998;16:2080-5.
17. Gronbaek K, Moller PH, Nedergaard T, et al. Primary cutaneous B-cell lymphoma: a clinical, histologic, phenotypic and genotypic study of 21 cases. Br J Dermatol 2000;142:913-23.
18. Hembury TA, Lee B, Gascoyne RD, et al. Primary cutaneous diffuse large B-cell lymphoma: a clinicopathologic study of 15 cases. Am J Clin Pathol 2002;117:574-80.
19. Hermine O, Haioun C, Lepage E, et al. Prognostic significance of bcl-2 protein expression in aggressive nonHodgkin's lymphoma: Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood 1996;87:265-72.
20. Huang JZ, Sanger WG, Greiner TC, et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 2002;99:2285-90.
21. Huebner-Chan D, Fernandes B, Yang G, et al. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone. Mod Pathol 2001;14:1000-7.
22. Jacobson JO, Wilkes BM, Kwaiatkowski DJ, et al. bcl-2 rearrangements in de novo diffuse large cell lymphoma: association with distinctive clinical features. Cancer 1993;72:231-6.
23. Kim BK, Surti U, Pandya A, et al. Primary and secondary cutaneous follicular lymphomas: a multiparameter study [Abstract]. Mod Pathol 2002;15:247.
24. King BE, Chen C, Locker J, et al. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas. Mod Pathol 2000;13:1219-31.
25. Kramer MH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 1998;92:3152-62.
26. Kurtin PJ, DiCaudo DJ, Habermann TM, et al. Primary cutaneous large cell lymphomas: morphologic, immunophenotypic, and clinical features of 20 cases. Am J Surg Pathol 1994;18:1183-91.
27. Larocca LM, Capello D, Rinelli A, et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 1998;92:1011-9.
28. Lo Coco F, Ye BH, Lista F, et al. Rearrangements of the BCL6 gene in diffuse large cell nonHodgkin's lymphoma. Blood 1994; 83:1757-9.
29. Mirza I, Macpherson N, Paproski S, et al. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features. J Clin Oncol 2002;20: 647-55.
30. Monni O, Franssila K, Joensuu H, et al. BCL2 overexpression in diffuse large B-cell lymphoma. Leuk Lymphoma 1999;34:45-52.
31. Nathwani BN, Weisenburger D, Isaacson PG, et al. Follicular lymphoma. In: Jaffe ES, Harris NL, Stein H, et al., eds. Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer, 2001:162-7.
32. Neri A, Fracchiolla NS, Roscetti E, et al. Molecular analysis of cutaneous B- and T-cell lymphomas. Blood 1995;86:3160-72.
33. Offit K, Lo Coco F, Louie DC, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma [see comments]. N Engl J Med 1994;331:74-80.
34. Pimpinelli N, Santucci M, Mori M, et al. Primary cutaneous B-cell lymphoma: a clinically homogeneous entity? J Am Acad Dermatol 1997;37:1012-6.
35. Rao PH, Houldsworth J, Dyomina K, et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998;92: 234-40.
36. Ree HJ, Yang WI, Kim CW, et al. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma. Hum Pathol 2001;32:954-62.
37. Rijlaarsdam JU, Toonstra J, Meijer OW, et al. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol 1996;14:549-55.
38. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47.
39. Russell-Jones R. Primary cutaneous B-cell lymphoma: how useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification? Br J Dermatol 1998;139:945-9.
40. Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer 1991;67: 2311-26.
41. Skinnider BF, Horsman DE, Dupuis B, et al. Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. Hum Pathol 1999;30:803-8.
42. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
43. Willemze R, Meijer CJ. EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer. Am J Dermatopathol 1999;21:265-73.
44. Willemze R, Meijer CJ. Rationale of a new classification for the group of primary cutaneous lymphomas. Semin Cutaneous Med Surg 2000;19:71-7.
45. Willemze R, Meijer CJ, Scheffer E, et al. Diffuse large cell lymphomas of follicular center cell origin presenting in the skin: a clinicopathologic and immunologic study of 16 patients. Am J Pathol 1987;126:325-33.
46. Willemze R, Meijer CJ, Sentis HJ, et al. Primary cutaneous large cell lymphomas of follicular center cell origin: a clinical follow-up study of nineteen patients. J Am Acad Dermatol 1987;16:518-26.